In prostate cancer, SELENOF deficiency promotes the Warburg effect (enhanced glycolysis); in breast cancer, overexpression can inhibit the PI3K/AKT pathway and induce cell apoptosis. This evidence concerns the gene SELENOF and breast carcinoma.